MedPath

The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization

Not Applicable
Completed
Conditions
Coronary Artery Disease
Chest Pain
Registration Number
NCT00644657
Lead Sponsor
University of Oklahoma
Brief Summary

This study will explore the effect of clopidogrel on coated-platelets in patients who are given a loading dose before diagnostic catheterization or percutaneous coronary intervention. We hypothesis that clopidogrel will reduce the percentage of platelets that are coated and therefore more hypercoagulable.

Detailed Description

Platelet activity will be determined by light transmission aggregometry at baseline, after a 300 mg dose of clopidogrel and after the catheterization and/or angioplasty procedure. The change in the percentage of platelets that are coated platelets will be determined.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
27
Inclusion Criteria
  • Patients given clopidogrel loading dose before scheduled catheterization or percutaneous intervention
Exclusion Criteria
  • Acute coronary syndrome
  • Unable to tolerate clopidogrel

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
The Percentage of Coated Platelets After the Administration of Clopidogrel in Patients Undergoing Cardiac Catheterization and/or Angioplasty24 hours after the administration of clopidotrel

The percentage of platelets that are collagen coated after the administration of clopidogrel.

Secondary Outcome Measures
NameTimeMethod
The Percentage of Coated Platelets After Coronary Angiography and/or PCI6 hrs after procedure

The percentage of coated platelets 24 hours after coronary angiography and/or PCI

Trial Locations

Locations (1)

VA Medical Center, 1F187

🇺🇸

Oklahoma City, Oklahoma, United States

© Copyright 2025. All Rights Reserved by MedPath